BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 23569189)

  • 1. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.
    Khan TA; Shah T; Prieto D; Zhang W; Price J; Fowkes GR; Cooper J; Talmud PJ; Humphries SE; Sundstrom J; Hubacek JA; Ebrahim S; Lawlor DA; Ben-Shlomo Y; Abdollahi MR; Slooter AJ; Szolnoki Z; Sandhu M; Wareham N; Frikke-Schmidt R; Tybjærg-Hansen A; Fillenbaum G; Heijmans BT; Katsuya T; Gromadzka G; Singleton A; Ferrucci L; Hardy J; Worrall B; Rich SS; Matarin M; Whittaker J; Gaunt TR; Whincup P; Morris R; Deanfield J; Donald A; Davey Smith G; Kivimaki M; Kumari M; Smeeth L; Khaw KT; Nalls M; Meschia J; Sun K; Hui R; Day I; Hingorani AD; Casas JP
    Int J Epidemiol; 2013 Apr; 42(2):475-92. PubMed ID: 23569189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E genotypes with lipid levels and coronary risk.
    Bennet AM; Di Angelantonio E; Ye Z; Wensley F; Dahlin A; Ahlbom A; Keavney B; Collins R; Wiman B; de Faire U; Danesh J
    JAMA; 2007 Sep; 298(11):1300-11. PubMed ID: 17878422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    Beilby JP; Hunt CC; Palmer LJ; Chapman CM; Burley JP; McQuillan BM; Thompson PL; Hung J;
    Stroke; 2003 Apr; 34(4):869-74. PubMed ID: 12637699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) Mass Levels Increase Significantly According to
    Moriarty PM; Varvel SA; Gordts PL; McConnell JP; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):580-588. PubMed ID: 28062489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism.
    Martins da Fonseca CS; Pimenta Filho AA; dos Santos BS; da Silva CA; Domingues AL; Owen JS; Lima VL
    PLoS One; 2014; 9(7):e101964. PubMed ID: 25051269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults.
    Viiri LE; Raitakari OT; Huhtala H; Kähönen M; Rontu R; Juonala M; Hutri-Kähönen N; Marniemi J; Viikari JS; Karhunen PJ; Lehtimäki T
    J Lipid Res; 2006 Jun; 47(6):1298-306. PubMed ID: 16528057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease.
    Lin Y; Yang Q; Liu Z; Su B; Xu F; Li Y; Kang J; Zhou Z
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.
    Al Harthi F; Huraib GB; Zouman A; Arfin M; Tariq M; Al-Asmari A
    Dis Markers; 2014; 2014():239645. PubMed ID: 24782577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals.
    Loktionov A; Scollen S; McKeown N; Bingham SA
    Br J Nutr; 2000 Dec; 84(6):885-90. PubMed ID: 11177205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
    Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
    Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.
    Ban C; Zhang Q; Feng J; Li H; Qiu Q; Tian Y; Li X
    BMC Psychiatry; 2017 Dec; 17(1):399. PubMed ID: 29233125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism and changes in serum lipids during a family-based counselling intervention.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2006 Oct; 9(7):859-65. PubMed ID: 17010251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis.
    Liang Y; Zhou Z; Wang H; Cheng X; Zhong S; Zhao C
    Epilepsy Behav; 2019 Sep; 98(Pt A):27-35. PubMed ID: 31299529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations.
    Viiri LE; Loimaala A; Nenonen A; Islam S; Vuori I; Karhunen PJ; Lehtimäki T
    Atherosclerosis; 2005 Mar; 179(1):161-7. PubMed ID: 15721023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
    Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
    Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.
    Volcik KA; Barkley RA; Hutchinson RG; Mosley TH; Heiss G; Sharrett AR; Ballantyne CM; Boerwinkle E
    Am J Epidemiol; 2006 Aug; 164(4):342-8. PubMed ID: 16760224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
    Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
    Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE Genotypes, Lipid Profiles, and Associated Clinical Markers in a Finnish Population with Cardiovascular Disease Risk Factors.
    Leskinen H; Tringham M; Karjalainen H; Iso-Touru T; Hietaranta-Luoma HL; Marnila P; Pihlava JM; Hurme T; Puolijoki H; Åkerman K; Mäkinen S; Sandell M; Vähäkangas K; Tahvonen R; Rokka S; Hopia A
    Lifestyle Genom; 2022; 15(2):45-54. PubMed ID: 34942620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population.
    Masemola ML; Alberts M; Urdal P
    Scand J Public Health Suppl; 2007 Aug; 69():60-5. PubMed ID: 17676504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.